Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5282281
Max Phase: Preclinical
Molecular Formula: C36H44N4O3
Molecular Weight: 580.77
Associated Items:
ID: ALA5282281
Max Phase: Preclinical
Molecular Formula: C36H44N4O3
Molecular Weight: 580.77
Associated Items:
Canonical SMILES: Oc1ccc2[nH]c3c(C4=C[C@@]5(O)CC/C=C\CCCCN6CC[C@@H]4[C@@]4(C6)CC67CCC(CCCN6[C@H]45)O7)nccc3c2c1
Standard InChI: InChI=1S/C36H44N4O3/c41-24-9-10-30-27(20-24)26-12-16-37-31(32(26)38-30)28-21-35(42)14-5-3-1-2-4-6-17-39-19-13-29(28)34(23-39)22-36-15-11-25(43-36)8-7-18-40(36)33(34)35/h1,3,9-10,12,16,20-21,25,29,33,38,41-42H,2,4-8,11,13-15,17-19,22-23H2/b3-1-/t25?,29-,33+,34-,35-,36?/m0/s1
Standard InChI Key: YFLBQKLEXJGASL-WTWIQLSXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 580.77 | Molecular Weight (Monoisotopic): 580.3413 | AlogP: 6.12 | #Rotatable Bonds: 1 |
Polar Surface Area: 84.85 | Molecular Species: BASE | HBA: 6 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.35 | CX Basic pKa: 10.11 | CX LogP: 3.93 | CX LogD: 1.81 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.30 | Np Likeness Score: 2.26 |
1. Luo B, Song X.. (2021) A comprehensive overview of β-carbolines and its derivatives as anticancer agents., 224 [PMID:34332400] [10.1016/j.ejmech.2021.113688] |
Source(1):